Repository logo
 
Publication

Antifungal and antibacterial activities of allicin: a review

dc.contributor.authorMarchese, A.
dc.contributor.authorBarbieri, R.
dc.contributor.authorSanches-Silva, A.
dc.contributor.authorDaglia, M.
dc.contributor.authorNabavi, S.F.
dc.contributor.authorJafari, N.J.
dc.contributor.authorIzadi, M.
dc.contributor.authorAjami, M.
dc.contributor.authorNabavi, S.M.
dc.date.accessioned2017-03-02T15:53:37Z
dc.date.available2020-04-07T00:30:11Z
dc.date.issued2016-06
dc.description.abstractBackground: Up until the early twentieth century infectious diseases were the most common and serious health problem worldwide, with degenerative disorders only dominating in certain parts of the world, such as Europe, relatively recently. As one of the most important challenges in the treatment of infection, much attention is currently focused on natural products as an alternative strategy against antibiotic resistance, due to their high therapeutic effects and low adverse reactions. Garlic is a well-known spice from the Alliaceae family that is widely used in traditional medicine for its wide variety of therapeutic properties, especially its potent antimicrobial effects. This species contains a unique class of organosulfur compound called allicin. A wide range of evidence has revealed the therapeutic effect of this compound on fungal and bacterial infection. Scope and approach: This paper critically reviews the available evidence of the antifungal and antibacterial activities of allicin. Its chemistry, bioavailability and natural sources are also discussed. Key findings and conclusions: During the past two decades, much attention has been focused on the antibacterial and antifungal potential of allicin against multi-drug resistant microorganisms. Despite promising in vitro results, the in vivo activity of allicin has not yet been well documented in preclinical and clinical efficacy trials. Due to some adverse effects, further studies are required to confirm the potential therapeutic use of allicin as an antimicrobial agent. Pharmacokinetic studies should be performed in order to improve the bioavailability of allicin by employing different delivery systems.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationTrends Food Sci Tech. 2016;52:49-56pt_PT
dc.identifier.doi10.1016/j.tifs.2016.03.010pt_PT
dc.identifier.issn0924-2244
dc.identifier.urihttp://hdl.handle.net/10400.18/4404
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevier/European Federation of Food Science and Technology (EFFoST), and the International Union of Food Science and Technology (IUFoST)pt_PT
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0924224416300073pt_PT
dc.subjectAllicinpt_PT
dc.subjectAntibacterialpt_PT
dc.subjectAntifungalpt_PT
dc.subjectGarlicpt_PT
dc.subjectInfectionpt_PT
dc.subjectComposição de Alimentospt_PT
dc.titleAntifungal and antibacterial activities of allicin: a reviewpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage56pt_PT
oaire.citation.startPage49pt_PT
oaire.citation.titleTrends in Food Science and Technologypt_PT
oaire.citation.volume52pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Allicin_TIFS_2016.pdf
Size:
359.25 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: